West Pharmaceutical Services

Yahoo Finance • 9 days ago

1 S&P 500 Stock on Our Buy List and 2 Facing Headwinds

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitor... Full story

Yahoo Finance • 17 days ago

FDVV vs. NOBL: Which Dividend Stock ETF Is a Better Buy?

Key Points The Fidelity High Dividend ETF has delivered 13.3% annualized return since September 2016. The ProShares S&P 500 Dividend Aristocrats ETF has underperformed it -- and the S&P 500 -- in recent years, while charging a higher expe... Full story

Yahoo Finance • 17 days ago

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks advanced late Tuesday afternoon, with the NYSE Healthcare Index and the State Stre PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 17 days ago

Stocks Retreat as Oil Prices Surge and Inflation Accelerates

The S&P 500 Index ($SPX) (SPY) today is down -0.74%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.55%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.45%.  June E-mini S&P futures (ESM26) are down -0.74%, and June E-mini Na... Full story

Yahoo Finance • 17 days ago

Stocks Pressured by Rising Oil Prices and Accelerating Inflation

The S&P 500 Index ($SPX) (SPY) today is down -0.44%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.74%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.72%.  June E-mini S&P futures (ESM26) are down -0.38%, and June E-mini Na... Full story

Yahoo Finance • 18 days ago

3 Healthcare Stocks We Steer Clear Of

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for... Full story

Yahoo Finance • last month

West to Participate in Upcoming Investor Conferences

EXTON, Pa., April 28, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor... Full story

Yahoo Finance • last month

3 Inflated Stocks with Open Questions

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase. But not e... Full story

Yahoo Finance • last month

Stocks Settle Lower on US-Iran Stalemate

The S&P 500 Index ($SPX) (SPY) on Thursday closed down -0.41%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.36%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.57%.  June E-mini S&P futures (ESM26) fell -0.42%, and... Full story

Yahoo Finance • last month

Stock Indexes Recover on Strength in Chipmakers

The S&P 500 Index ($SPX) (SPY) today is up +0.07%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.05%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.03%.  June E-mini S&P futures (ESM26) are up +0.07%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • last month

Stocks Pressured as Peace Talks with Iran Remain in Limbo

The S&P 500 Index ($SPX) (SPY) today is down -0.07%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.36%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.03%.  June E-mini S&P futures (ESM26) are down -0.08%, and June E-mini Na... Full story

Yahoo Finance • last month

West Pharmaceutical Services, Inc. Q1 2026 Earnings Call Summary

West Pharmaceutical Services, Inc. Q1 2026 Earnings Call Summary - Moby Strategic Performance Drivers First quarter organic revenue growth of 15.3% was driven by broad-based demand across all segments, particularly High-Value Product (HV... Full story

Yahoo Finance • last month

West Pharmaceutical Q1 Non-GAAP Earnings, Net Sales Rise; Issues Q2 Guidance -- Shares Rise Pre-Bell

West Pharmaceutical Services (WST) reported Q1 non-GAAP earnings Thursday of $2.13 per diluted share PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

West Reports First-Quarter 2026 Results

Strong Start to the Year and Raising Full-Year Revenue and EPS guidance EXTON, Pa., April 23, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and ser... Full story

Yahoo Finance • 2 months ago

Will CEO Succession and Chair Role Debate Reshape West Pharmaceutical’s Governance Story (WST)?

In early March 2026, West Pharmaceutical Services announced that long-time President, CEO and Board Chair Eric M. Green plans to retire in the second half of 2026, reaffirmed its February 12, 2026 guidance, and later received a shareholder... Full story

Yahoo Finance • 3 months ago

3 Reasons to Sell WST and 1 Stock to Buy Instead

West Pharmaceutical Services has been treading water for the past six months, recording a small loss of 2.7% while holding steady at $248.28. The stock also fell short of the S&P 500’s 3.1% gain during that period. Is there a buying oppor... Full story

Yahoo Finance • 3 months ago

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

Check out some of the companies making the biggest moves midday: Hims & Hers Health – Shares of the telehealth company jumped 3%. Bank of America upgraded the stock to neutral from underperform after Novo Nordisk dropped its patent infring... Full story

Yahoo Finance • 3 months ago

Thursday Sector Laggards: Healthcare, Industrial

Looking at the sectors faring worst as of midday Thursday, shares of Healthcare companies are underperforming other sectors, showing a 0.1% loss. Within that group, West Pharmaceutical Services, Inc. (Symbol: WST) and Zoetis Inc (Symbol:... Full story

Yahoo Finance • 3 months ago

1 S&P 500 Stock on Our Watchlist and 2 We Find Risky

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitor... Full story

Yahoo Finance • 3 months ago

Notable healthcare headlines for the week: Viatris, Novo Nordisk, and Gilead Sciences in focus

Wall Street’s major market averages finished lower on Friday after the January wholesale inflation report came in hotter than expected. The blue-chip Dow was last lower by 1%, while the benchmark S&P 500 was -0.4%. At the same time, the t... Full story